Sanford-Burnham Medical Research Institute, La Jolla, California 92037, USA.
J Biol Chem. 2012 Aug 10;287(33):28047-56. doi: 10.1074/jbc.M112.382333. Epub 2012 Jun 18.
We used a comparative genomics approach to reconstruct the N-acetyl-d-galactosamine (GalNAc) and galactosamine (GalN) utilization pathways and transcriptional regulons in Proteobacteria. The reconstructed GalNAc/GalN utilization pathways include multiple novel genes with specific functional roles. Most of the pathway variations were attributed to the amino sugar transport, phosphorylation, and deacetylation steps, whereas the downstream catabolic enzymes in the pathway were largely conserved. The predicted GalNAc kinase AgaK, the novel variant of GalNAc-6-phosphate deacetylase AgaA(II) and the GalN-6-phosphate deaminase AgaS from Shewanella sp. ANA-3 were validated in vitro using individual enzymatic assays and reconstitution of the three-step pathway. By using genetic techniques, we confirmed that AgaS but not AgaI functions as the main GalN-6-P deaminase in the GalNAc/GalN utilization pathway in Escherichia coli. Regulons controlled by AgaR repressors were reconstructed by bioinformatics in most proteobacterial genomes encoding GalNAc pathways. Candidate AgaR-binding motifs share a common sequence with consensus CTTTC that was found in multiple copies and arrangements in regulatory regions of aga genes. This study provides comprehensive insights into the common and distinctive features of the GalNAc/GalN catabolism and its regulation in diverse Proteobacteria.
我们采用比较基因组学方法重建了变形菌中的 N-乙酰-d-半乳糖胺(GalNAc)和半乳糖胺(GalN)利用途径和转录调控因子。重建的 GalNAc/GalN 利用途径包括具有特定功能作用的多个新基因。途径变化的大部分归因于氨基糖的转运、磷酸化和去乙酰化步骤,而途径下游的分解代谢酶则在很大程度上保守。预测的 GalNAc 激酶 AgaK、Shewanella sp. ANA-3 中的新型 GalNAc-6-磷酸去乙酰化酶 AgaA(II)变体和 GalN-6-磷酸脱氨酶 AgaS 通过单独的酶促测定和三步途径的重建在体外得到了验证。通过遗传技术,我们证实 AgaS 而不是 AgaI 是大肠杆菌中 GalNAc/GalN 利用途径中主要的 GalN-6-P 脱氨酶。在大多数编码 GalNAc 途径的变形菌基因组中,通过生物信息学重建了由 AgaR 抑制剂控制的调控子。候选 AgaR 结合基序与 aga 基因调控区中发现的多个重复和排列的共识 CTTTC 具有共同序列。本研究全面了解了不同变形菌中 GalNAc/GalN 代谢及其调控的共同和独特特征。